MetaCap

Neuropace Inc. Company Profile

NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD

12.39-0.37 (-2.90%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 12.39 0.00%

Neuropace at a glance

Neuropace Inc. (NASDAQ: NPCE) is a Medical/Dental Instruments company in the Health Care sector headquartered in Mountain View, CA. Neuropace is led by Mr. Joel D. Becker and employs about 220 people. The company's shares have traded publicly since 2021.

At a market capitalization of $434.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001528287, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Neuropace do?

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Business description based on the company's public filings.

Company information

Legal name
Neuropace Inc.
Ticker
NASDAQ: NPCE
Industry
Medical/Dental Instruments
CEO
Mr. Joel D. Becker
Employees
220
Headquarters
455 North Bernardo Avenue, Mountain View, CA, United States
Phone
650 237 2700
IPO year
2021
Market cap
$434.89M
SEC CIK
0001528287

Companies similar to Neuropace

NPCE peer companies
CompanyPrice% ChgMarket capCompare
RCELAvita Medical Inc.13.33+2.15%$412.25Mvs NPCE
CERSCerus Corporation2.28-0.44%$459.48Mvs NPCE
BWAYBrainsWay Ltd. ADR11.47-1.29%$461.70Mvs NPCE
SGHTSight Sciences Inc.8.470.00%$466.60Mvs NPCE
ANGOAngioDynamics Inc.11.23-20.86%$472.27Mvs NPCE
SENSSenseonics Holdings Inc.9.02-1.53%$476.92Mvs NPCE
CARLCarlsmed Inc.14.05-2.29%$383.60Mvs NPCE
SIShoulder Innovations Inc.17.89-4.38%$372.45Mvs NPCE

Related